08/14/2025
4:32 PM | BioMarin Pharmaceutical (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SCHEDULE 13G/A | |
08/14/2025
11:43 AM | BioMarin Pharmaceutical (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
| Form SCHEDULE 13G/A | |
08/05/2025
5:51 PM | BioMarin Pharmaceutical (Issuer)
CLARK IAN T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/05/2025
5:55 PM | BioMarin Pharmaceutical (Issuer)
CLARK IAN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
12:03 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/01/2025
8:18 AM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-T/A | |
06/17/2025
6:28 AM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-T/A | |
06/04/2025
3:32 PM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-T/A | |
06/02/2025
5:25 AM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-T | |
05/20/2025
4:58 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
8:58 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for BMRN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioMarin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. |
05/19/2025
4:22 PM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-C | |
05/16/2025
8:44 PM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-C | |
05/16/2025
4:16 PM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-C | |
05/16/2025
6:54 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2025
6:59 AM | BioMarin Pharmaceutical (Subject)
| Form SC TO-C | |
05/13/2025
10:32 AM | BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
| Form SCHEDULE 13G/A | |
05/02/2025
11:33 AM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2025
9:05 AM | BioMarin Pharmaceutical (Subject)
Hubbard Cristin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2025
8:14 AM | BioMarin Pharmaceutical (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
04/08/2025
3:09 PM | BioMarin Pharmaceutical (Filer)
| Form DEF 14A | |
04/08/2025
3:12 PM | BioMarin Pharmaceutical (Filer)
| Form DEFA14A | |
03/20/2025
6:38 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
8:36 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
6:51 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
6:53 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:23 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:25 PM | BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:17 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:19 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:22 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:11 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:15 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:17 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:19 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:18 PM | BioMarin Pharmaceutical (Issuer)
Walbert Timothy P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:21 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
12:54 PM | BioMarin Pharmaceutical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
9:26 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
3:07 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
1:14 PM | BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
| Form SCHEDULE 13G/A | |
How “Trump’s New Dollar” Could Impact Your Wealth (Ad) President Trump just signed a game-changing law…
That could soon upgrade the U.S. dollar in your checking and savings account…
With this better, more technologically advanced dollar.
President Trump himself called it a "big innovation"…
And said that this new form of currency represents "American brilliance at its best." Click here now because Chase, Bank of America, Citigroup, Wells Fargo, and U.S. Bancorp… |
12/03/2024
5:15 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
1:44 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
1:27 PM | BioMarin Pharmaceutical (Subject)
Guyer Charles Greg (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
2:01 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/01/2024
3:50 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
3:51 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:29 PM | BioMarin Pharmaceutical (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G | |
09/24/2024
7:31 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:54 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
11:52 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
